title: [Current status of preclinical therapy of myocardial infarct].
abstract: The mortality associated with myocardial infarction can be considerably reduced by the use of thrombolysis, the success rate being determined largely by the time elapsing between attack and treatment. Despite various campaigns to inform the public, the time elapsing between symptom onset and alerting the doctor continues to be measured in hours. In view of the possible complications that may occur already during patient transport to the hospital, the emergency physician should be involved immediately. Basic treatment comprises the administration of oxygen, sedatives, analgesics and nitrates. Initiation of thrombolysis by the emergency physician is associated with a number of difficulties (uncertainty of diagnosis, equipment, experience). Since prehospital thrombolysis has not yet been shown to be of general advantage, it may be recommended only when transport is long and when the personnel and equipment requirements are met. The greatest benefit is to be expected from a shortening of the time lapse before alerting the doctor.
authors.affiliation: Medizinische Klinik, Stiftsklinik Augustinum, München.
authors.forename: M
authors.initials: M
authors.lastname: Markreiter
authors.forename: R
authors.initials: R
authors.lastname: von Essen
mesh_terms: D000552:Ambulances; D004630:Emergencies; D005392:First Aid; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality; D015996:Survival Rate; D015912:Thrombolytic Therapy
vernacular_title: Heutiger Stand der präklinischen Infarkttherapie.